Hutchin Hill Capital’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-71,300
Closed -$1.89M 950
2017
Q2
$1.89M Buy
71,300
+18,600
+35% +$496K 0.06% 337
2017
Q1
$1.44M Buy
52,700
+11,900
+29% +$304K 0.04% 395
2016
Q4
$1.01M Buy
+40,800
New +$860K 0.03% 460
2016
Q3
Sell
-48,700
Closed -$921K 708
2016
Q2
$921K Buy
+48,700
New +$1.02M 0.03% 363
2015
Q3
Sell
-46,500
Closed -$1.39M 744
2015
Q2
$1.39M Buy
+46,500
New +$1.31M 0.04% 386
2014
Q3
Sell
-48,543
Closed -$1.34M 713
2014
Q2
$1.34M Buy
+48,543
New +$1.33M 0.06% 279

Other funds holding TBI

Hutchin Hill Capital's TBI Position: Q3 2017 in Review

Hutchin Hill Capital sold out of Trueblue (TBI) in Q3 2017, closing a stake of 71,300 shares — an estimated $1.89M sold.

Hutchin Hill Capital first reported a position in TBI in Q2 2014 and held it in 6 quarters. The position peaked at $1.89M in Q2 2017. 191 funds tracked by Wall St. Rank hold TBI as of Q3 2017.

  • Hutchin Hill Capital reported no remaining Trueblue position as of Q3 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 71,300 Trueblue shares in Q3 2017, an estimated $1.89M.
  • Hutchin Hill Capital first reported a position in Trueblue in Q2 2014 and held it in 6 quarters.
  • Hutchin Hill Capital's Trueblue position peaked at $1.89M in Q2 2017.
  • 191 funds tracked by Wall St. Rank held Trueblue as of Q3 2017.

Based on Hutchin Hill Capital's 13F filing for Q3 2017, filed 14 Nov 2017.